The Genetic Link

Welcome to The Genetic Link, a blog providing new insights into DNA and RNA sample collection by DNA Genotek. DNA Genotek is a subsidiary of OraSure Technologies, Inc.

All Posts

Article by: Elizabeth Firth

Saliva sample to sequencer in under 8 hours


A new solution to a workflow challenge with Twist Bioscience

It's no secret that the global genomics market has grown in recent years. Growth is often accompanied by new challenges and higher expectations. Genomics laboratories can attest to this as many are in the midst of searching for innovative solutions to increase the speed at which they can process samples while maintaining their quality of work.

We at DNA Genotek began collaborating with Twist Bioscience, a manufacturer of synthetic DNA, on an end-to-end solution to address time-consuming and costly Next Generation Sequencing (NGS) laboratory workflows. This blog specifically highlights our efforts around improving the workflow for DNA isolation through targeted enrichment and whole exome sequencing.

The goal of this collaboration was to achieve a single day workflow ‑ sample to sequencer in under 8 hours ‑ and more importantly, do so without sacrificing quality or performance.

We targeted an 8-hour workflow so technicians could start their day with DNA saliva sample in hand, and leave at the end of their day with samples on a sequencer. 

Locating the bottleneck and addressing the problem

We began examining a typical DNA sample processing workflow with an eye on where we could improve the DNA isolation process. We concluded that sample preparation, quantification and normalization added significant time to the workflow and that we would need to reduce the duration of these steps to have a meaningful impact on the overall workflow.

This would require the development of an innovative new reagent. We were successful in this endeavor and have launched prepIT·Q2A which enables a rapid, liquid-based removal of inhibitors found in Oragene® and ORAcollect® saliva samples. The protocols are adaptable for manual or automated processing with a preparation time of only 30 minutes.

While we addressed the upstream workflow, Twist focused their efforts on the downstream. Twist quickly recognized that its 16-hour hybridization was the longest step of the 2-day process and targeted it for improvement. Out of those development efforts, the new TWIST FAST HYB kit was born. This new product was designed specifically to reduce the lengthy hybridization step to as little as 15 minutes.

How much faster was this new end-to-end solution?

Bringing together our expertise in DNA from saliva isolation and Twist’s FAST HYB kit and targeted enrichment technology, we were able to shave over 24 hours off the overall workflow to deliver a streamlined, 8 hour, workflow.

The end-to-end solution is automatable and customizable to deliver not only workflow efficiencies, but also overall cost reductions, making it ideal for any laboratory interested in scaling up their sample throughput.

“Having the rapid, easy to use, robust, and automatable prepIT®•Q2A isolation upstream workflow for saliva DNA samples integrated into the TWIST Bioscience fast enrichment system and targeted sequencing downstream enables a sample to be sequenced in one day with reliable quality.” – Bryan Hoglund, product manager at Twist Bioscience.

Another successful collaboration

We're happy to have had the opportunity to collaborate with Twist Bioscience and we look forward to learning how we can help implement this streamlined workflow in your lab.

prepIT•Q2A is now available. You can find more information on the prepIT·Q2A product page or email us at

Click the link to learn more about Twist Bioscience NGS target enrichment solutions.

Request free trial kits of any DNA Genotek saliva kit

Elizabeth Firth
Elizabeth Firth
Human genomics product manager

Subscribe and Get Our Latest Posts

Type Your Email Address

Recent Posts

Highlights from the 2023 European Society of Human Genetics conference

Like last year, this year’s annual European Society of Human Genetics (ESHG) conference was a hybrid even...
Sanna Abbasi, PhD Jul 18, 2023 4:22:54 PM

A faster and more affordable path to FDA clearance

When developing a clinical or diagnostic test or assay for patient use, a strong indicator of device effe...
Sanna Abbasi, PhD, and Jayden Hess Jul 10, 2023 11:51:00 AM

Revisiting the Saliva and Liquid Sampling Australia 2023 conference

From May 31st to June 2nd, 2023, the fourth Saliva and Liquid Australia (SALSA) conference was held both ...
Sanna Abbasi, PhD Jul 5, 2023 10:39:13 AM